# Moleac

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/moleac

- Industry: Pharmaceuticals
- Headquarters: Singapore, Singapore
- Website: www.moleac.net
- Total disclosed funding: $3.5M
- Latest round: Series A (Apr 3, 2008)
- Investors on record: 1

## About

Moleac is a specialty pharma company which identifies promising traditional Chinese medicines (TCMs) and which develops them as Western medicine (“modernizing” TCMs). Focusing on unmet medical needs, Moleac drives research, development and registration for a pipeline of drugs and devices. Its first product Neuroaid, which helps patients recover from a stroke, is now marketed in more than 30 countries and continues to undergo clinical trials to extend its indications. The company is also implementing further research on identifying underlying mechanisms of actions.

## Funding rounds

- Series A, Apr 3, 2008, $3.5M — Hunza Ventures

## Investors

- Hunza Ventures (https://capitalatlas.ai/funds/hunza-ventures) — Series A